1. Home
  2. GOSS vs PGC Comparison

GOSS vs PGC Comparison

Compare GOSS & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$0.50

Market Cap

615.7M

Sector

Health Care

ML Signal

N/A

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

N/A

Current Price

$34.28

Market Cap

607.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
PGC
Founded
2015
1921
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
607.2M
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
GOSS
PGC
Price
$0.50
$34.28
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$4.91
$39.33
AVG Volume (30 Days)
27.3M
119.5K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
0.59%
EPS Growth
78.81
N/A
EPS
N/A
1.42
Revenue
$114,701,000.00
$228,128,000.00
Revenue This Year
N/A
$31.45
Revenue Next Year
N/A
$12.54
P/E Ratio
N/A
$23.86
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$23.96
52 Week High
$3.87
$35.68

Technical Indicators

Market Signals
Indicator
GOSS
PGC
Relative Strength Index (RSI) 23.06 58.22
Support Level $0.33 $26.68
Resistance Level $1.23 $35.37
Average True Range (ATR) 0.09 1.16
MACD -0.00 -0.16
Stochastic Oscillator 8.98 75.19

Price Performance

Historical Comparison
GOSS
PGC

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

Share on Social Networks: